Search
Pemigatinib
go.drugbank.com/drugs/DB15102ApprovedInvestigationalPemigatinib is a small molecule kinase inhibitor with antitumour activity. It works by inhibiting fibroblast growth factor receptors (FGFRs), which are receptor tyrosine kinases that activate signalling pathways in tumour cells. FGFRs ga...
(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid
go.drugbank.com/drugs/DB08552ExperimentalThese are aromatic compounds containing at least one benzene ring. This medication targets the protein beta-lactamase.
Potassium hydroxide
go.drugbank.com/drugs/DB11153ApprovedPotassium hydroxide, also known as lye is an inorganic compound with the chemical formula KOH. Also commonly referred to as caustic potash, it is a potent base that is marketed in several forms including pellets, flakes, and powders. It ...
Eucalyptus oil
go.drugbank.com/drugs/DB11114ApprovedEucalyptus oil is a distilled oil derived from the leaves of the tree Eucalyptus. It is shown to be effective in reducing pain, swelling, and inflammation via its modulatory effect on the immune response. It is also shown to exhibit anti...
Categories: Complex Mixtures9-(4-hydroxybutyl)-N2-phenylguanine
go.drugbank.com/drugs/DB02495ExperimentalThese are compounds containing the purine derivative 1H-purin-6(9H)-one. 9-(4-hydroxybutyl)-n2-phenylguanine is known to target thymidine kinase.
Ozanimod
go.drugbank.com/drugs/DB12612ApprovedInvestigationalOzanimod is a once-daily sphingosine 1-phosphate receptor modulator for the treatment of relapsing Multiple Sclerosis (MS) and inflammatory bowel disease.
Eslicarbazepine acetate
go.drugbank.com/drugs/DB09119ApprovedInvestigationalIt is available in 200, 400, 600, or 800mg tablets that are taken once daily, with or without food.
Manganese gluconate
go.drugbank.com/drugs/DB11141ApprovedManganese gluconate is a manganese salt of gluconic acid with the chemical formula C12H22MnO14 x 2H2O. It is typically obtained by reacting manganese carbonate with gluconic acid in aqueous medium and then crystallizing the product to fo...
Mixtures: Swiss One Timed Release TabLeuprolide
go.drugbank.com/drugs/DB00007ApprovedInvestigational[L13850] Since this initial approval, various long-acting intramuscular and subcutaneous products have been developed such that patients can be dosed once every six months.